Clinical Trial Update: Emicizumab in Acquired Hemophilia A [Phase 2]

View source ↗

Summary

Phase 2 trial update on emicizumab for acquired hemophilia A has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia Acquired

Drugs mentioned

• Emicizumab (emicizumab)

Snippet

Sponsor: GWT-TUD GmbH | Conditions: Hemophilia A, Acquired | Phase 2 | Status: COMPLETED